C677T-SNP of methylenetetrahydrofolate reductase gene and breast cancer in Mexican women
Main Article Content
Keywords
Penetrance, Genetic predisposition to disease, Breast cancer, Women, Mexico
Abstract
Background: Low-penetrance susceptibility genes such as 5,10-methylenetetrahydrofolate reductase gene (MTHFR) have been considered in the progression of breast cancer (BC). Cancer is a result of genetic, environmental and epigenetic interactions; therefore, these genes should be studied in environmental context, because the results can vary between populations and even within the same country. The objective was to analyze the allelic and genotypic frequencies of the MTHFR C667T SNP in Mexican Mestizo patients with BC and controls from Northeastern Mexico.
Methods: 243 patients and 118 healthy women were studied. The analysis of the polymorphism was performed with a DNA microarray. Once the frequency of the polymorphism was obtained, Hardy-Weinberg equilibrium test was carried out for the genotypes. Chi square test was used to compare the distribution of frequencies.
Results: The allele frequency in patients was: C = 0.5406; T = 0.4594 and in controls C = 0.5678, T = 0.4322. Genotype in BC patients was: C / C = 29.9%, C / T = 48.3% and T / T = 21.8. The distribution in controls was: C / C = 31.4%, C / T = 50.8%, T / T = 17.8% (chi squared 0.77, p = 0.6801).
Conclusions: Northeastern Mexican women in this study showed no association between MTFHR C667T SNP and the risk of BC. It seems that the contribution of this polymorphism to BC in Mexico varies depending on various factors, both genetic and environmental.
References
Larsen MJ, Thomassen M, Gerdes AM, Kruse TA. Hereditary breast cancer: clinical, pathological and molecular characteristics. Breast Cancer (Auckl) 2014;8:145-55.
Li K, Li W, Dong X. Association of 677 C.T (rs1801133) and 1298 A.C (rs1801131) Polymorphisms in the MTHFR Gene and Breast Cancer Susceptibility: A Meta-Analysis Based on 57 Individual Studies. PLoS ONE 2014; 9(6): e71290.
Akram M, Malik FA, Kayani MA. Mutational analysis of the MTHFR gene in breast cancer patients of Pakistani population. Asian Pac J Cancer Prev. 2012;13 (4):1599-603.
Nitsche-V F, Alliende-R MA, Santos-M JL , Pérez-B F, Santa María-V L, Hertrampf-D E et al. Frecuencia del polimorfismo C677T de la 5, 10-metilentetrahidrofolato reductasa (MTHFR) en mujeres chilenas madres de afectados con espina bífida y en controles normales. Rev Méd Chile 2003;131(12):1399-404.
García-Robles R, Ayala-Ramírez PA, Villegas VE, Salazar M, Bernal J, Núñez F et al. Estudio del polimorfismo MTHFR C677T en recién nacidos con cardiopatías congénitas aisladas, en una población colombiana Univ. Med. Bogotá (Colombia) 2011;52(3):269-77.
Sánchez-Urbina R, Galaviz-Hernández C, Sierra-Ramírez A, Rangel-Villalobos H, Torres-Saldúa R, Alva-Espinoza C, et al. Polimorfismo 677CT del gen de la metilentetradihidrofolato reductasa y cardiopatías congénitas aisladas en población mexicana. Rev Esp Cardiol. 2012; 65(2):158-63.
Ubeda N, Reyes L, González-Medina A, Alonso-Aperte E, Varela-Moreiras G. Physiologic changes in homocysteine metabolism in pregnancy: a longitudinal study in Spain. Nutrition. 2011;27(9):925-30.
Diakite B, Tazzite A, Hamzi K, Jouhadi H, Nadifi S. Methylenetetrahydrofolate reductase C677T polymorphism and breast cancer risk in Moroccan women. African Health Science. 2012;204- 209.
Yafei W, Lijun P, Jinfeng W, Xiaoying Z. Is the prevalence of MTHFR C677T polymorphism associated with ultraviolet radiation in Eurasia? J of Hum Genet. 2012;57,780-6.
Weiwei Z, Liping C, Dequan L. Association between dietary intake of folate, vitamin B6, B12 & MTHFR, MTR Genotype and breast cancer risk. Pak J Med Sci. 2014;30(1):106-10.
Lajin B, Alhaj Sakur A, Ghabreau L, Alachcar A. Association of polymorphisms in one-carbon metabolizing genes with breast cancer risk in Syrian women. Tumour Biol. 2012; 33(4):1133-9.
Zhang XF, Liu T, Li Y, Li S. Association between MTHFR 677C/T and 1298A/C gene polymorphisms and breast cancer risk. Genet Mol Res. 2015;14 (4),16425-30.
Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 1997; 94:3290-5.
Zara-Lopes T, Gimenez-Martins AP, Nascimento-Filho CH, Castanhole-Nunes MM, Galbiatti-Dias AL, Padovani-Júnior JA, et al. Role of MTHFR C677T and MTR A2756G polymorphisms in thyroid and breast cancer development. Genet Mol Res. 2016;15(2). doi: 10.4238/gmr.15028222. Disponible en http://www.geneticsmr.com/sites/default/files/articles/year2016/vol15-2/pdf/gmr8222_1.pdf
Batschauer AP, Cruz NG, Oliveira VC, Coelho FF, Santos IR, Alves MT, et al. HFE, MTHFR, and FGFR4 genes polymorphisms and breast cancer in Brazilian women. Mol Cell Biochem. 2011;357(1-2):247-53.
Ruiz-Linares A, Adhikari K, Acuña-Alonzo V, Quinto-Sanchez M, Jaramillo C, Arias W, et al. Admixture in Latin America: Geographic Structure, Phenotypic Diversity and Self-Perception of Ancestry Based on 7,342 Individuals. PLoS Genet. 2014;10(9): e1004572.
Hernández-Guerrero C, Romo-Palafox I, Díaz-Gutiérrez MC, Iturbe-García M, Texcahua-Salazar A, Pérez-Lizaur AB. Prevalence of metilentetrahidrofolate reductase C677T polymorphism, consumption of vitamins B6, B9, B12 and determination of lipidic hydroperoxides in obese and normal weight Mexican population. Nutr Hosp. 2013;28(6):2142-50.
Ramos-Silva A, Figuera LE, Soto-Quintana OM, Puebla-Pérez AM, Ramirez-Patiño R, Gutiérrez-Hurtado I, et al. Association of the C677T polymorphism in the methylenetetrahydrofolate reductase gene with breast cancer in a Mexican population. Genet Mol Res. 2015;14:4015-26.
Yang B, Liu Y, Li Y, Fan S, Zhi X, Lu X, et al. Geographical Distribution of MTHFR C677T, A1298C and MTRR A66G Gene Polymorphisms in China: Findings from 15357 Adults of Han Nationality. PloS ONE. 2013;8(3):e57917.
Hamner HC, Tinker SC. Fortification of corn masa flour with folic acid in the United States: an overview of the evidence. Ann N Y Acad Sci. 2014;1312:8-14.